CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
RELEVIUM aims to enhance the quality of life for advanced pancreatic cancer patients by implementing personalized nutrition, physical activity, and pain management strategies alongside chemotherapy. The project utilizes digital tools, including a smartwatch and remote monitoring technologies, to empower patients in man…
Pancreatic cancer has the lowest survival rate amongst other cancers and is responsible for 95,000 deaths every year in the EU.
Its treatment is usually palliative, aiming at slowing tumour progression and at symptom management.The main hypothesis of RELEVIUM is that quality of life (QoL) of advanced pancreatic cancer patients can be significantly improved by reducing pain and cachexia through highly personalised nutrition, physical activity, and pain management strategies, in addition to chemot…
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAET MAINZ
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
JOHANNES GUTENBERG-UNIVERSITAT MAINZ
Germany, Mainz
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
CENTRE FOR RESEARCH AND TECHNOLOGY HELLAS CERTH
Greece, Thermi Thessaloniki
Type: Research institute
Activity type: Research Organisations
SME: No
HAROKOPIO UNIVERSITY OF ATHENS (HUA)
Greece, ATHINA
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
Guests see up to 5 keywords.
